About: Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force
Creator	Molinari, Marco Manto, Mario Mitoma, Hiroshi Schmahmann, Jeremy Dupre, Nicolas Hadjivassiliou, Marios Louis, Elan Overwalle, Van Shaikh, Aasef Soong, Bing-Wen Strupp, Michael Ag, Shaikh Chen, Tsang-Shan Dupre, Manto Ed, Louis Hospital, Sin-Lau Hsieh, Cheng-Yang Jd, Schmahmann Overwalle, Frank Pinzon, Taslim Rizaldy, Taiwan Soong B-W, Strupp
source	Medline; PMC
abstract	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), the cause of the current pandemic coronavirus disease 2019 (COVID-19), primarily targets the respiratory system. Some patients also experience neurological signs and symptoms ranging from anosmia, ageusia, headache, nausea, and vomiting to confusion, encephalitis, and stroke. Approximately 36% of those with severe COVID-19 experience neurological complications. The virus may enter the central nervous system through the olfactory nerve in the nasal cavity and damage neurons in the brainstem nuclei involved in the regulation of respiration. Patients with cerebellar ataxia (CA) are particularly vulnerable to severe outcome if they contract COVID-19 because of the complexity of their disease, the presence of comorbidities, and their use of immunosuppressive therapies. Most CA patients burdened by progressive neurologic deficits have substantially impaired mobility and other essential functions, for which they rely heavily on ambulatory services, including rehabilitation and psychosocial care. Cessation of these interventions because of isolation restrictions places the CA patient population at risk of further deterioration. This international panel of ataxia experts provides recommendations for neurologists caring for patients with CA, emphasizing a pro-active approach designed to maintain their autonomy and well-being: continue long-term medications, promote rehabilitation efforts, utilize the technology of virtual visits for regular contact with healthcare providers, and pay attention to emotional and psychosocial health. Neurologists should play an active role in decision-making in those CA cases requiring escalation to intensive care and resuscitation. Multi-disciplinary collaboration between care teams is always important, and never more so than in the context of the current pandemic.
has issue date	2020-05-22(xsd:dateTime)
bibo:doi	10.3389/fneur.2020.00516
bibo:pmid	32574247
has license	cc-by
sha1sum (hex)	0a12ac257334cecd9952657a56c0c340a47c727d
schema:url	https://doi.org/10.3389/fneur.2020.00516
resource representing a document's title	Medical and Paramedical Care of Patients With Cerebellar Ataxia During the COVID-19 Outbreak: Seven Practical Recommendations of the COVID 19 Cerebellum Task Force
has PubMed Central identifier	PMC7274029
has PubMed identifier	32574247
schema:publication	Front Neurol
resource representing a document's body	covid:0a12ac257334cecd9952657a56c0c340a47c727d#body_text
is schema:about of	named entity 'Recommendations' named entity 'COVID' named entity 'general population' named entity 'ACE2' named entity 'neurological diseases' named entity 'diabetes' named entity 'healthcare providers' named entity 'coronavirus disease' named entity 'nuclei' named entity 'peripheral nervous' named entity 'corona virus' named entity 'COVID-19' named entity 'anosmia' named entity 'ataxic' named entity 'pulmonary disease' named entity 'neurologists' named entity 'cerebellar' named entity 'spinocerebellar ataxias' named entity 'corticosteroids' named entity 'immunosuppressive drugs' named entity 'evidence-based guidelines' named entity 'elderly people' named entity 'central nervous' named entity 'neurological disorders' named entity 'COVID-19' named entity 'signs and symptoms' named entity 'COVID' named entity 'hospice' named entity 'mental flexibility' named entity 'neurologists' named entity 'quarantine' named entity 'ageusia' named entity 'immune-mediated' named entity 'intubation' named entity 'neuropsychiatric' named entity 'Cerebellar ataxias' named entity 'suicide' named entity 'attentional control' named entity 'telemedicine' named entity 'encephalitis' named entity 'Patients' named entity 'Cerebellar Ataxia' named entity 'Cerebellum' named entity 'neurological complications' named entity 'severe acute respiratory syndrome coronavirus 2' named entity 'telemedicine' named entity 'intubation' named entity 'decision-making' named entity 'anxiety' named entity 'social media' named entity 'intensive care units' named entity 'COVID-19' named entity 'fatigue' named entity 'SARS-CoV' named entity 'pulmonary complications' named entity 'resuscitation' named entity 'social isolation' named entity 'ventilator' named entity 'multi-disciplinary' named entity 'ICU'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software